About My Health Careers Internship MedBlogs Contact us

Drug Trials for Diabetes a Mirage or a Reality?

by Medindia Content Team on September 29, 2007 at 12:04 PM
Font : A-A+

Drug Trials for Diabetes a Mirage or a Reality?

The suggestion was made by Mayo Clinic researchers who said that diabetes medications have been approved without requiring proof that they reduce the risk of complications associated with diabetes. Therefore it is important to understand the outcomes that are important to patients.

The authors pointed out that the majority of clinical trials focus on the effect of a particular medication on blood sugar levels. The result is that smaller, shorter and cheaper trials lead to more drug choices more quickly, but are not necessarily better or safer for patients.


"The apparent benefits of these trials are a mirage and the apparent savings represent false economy," The Lancet quoted Victor Montori, M.D., an endocrinologist at Mayo Clinic, along with Gunjan Gandhi, M.D., of Mayo Clinic, and Gordon Guyatt, M.D., of McMaster University in Canada, as writing in their commentary.

"Any savings are quickly overwhelmed by expenses associated with potentially ineffective, or even harmful, expensive therapies and the incremental costs of treating the harms these interventions might cause. Patients and society may end up paying dearly for medications that cause more harm than good," the authors added.

The authors have said that the medical community is increasingly aware of the need to engage patients with chronic conditions in decisions about their care. For example, clinicians and patients need to know the extent to which diabetes medications can help patients feel better and live longer.

Despite this need, only one in five randomised trials in diabetes published in top medical journals measured the effect of drugs on quality of life and on the risk of complications associated with diabetes.

Therefore, Dr. Montori and colleagues call for clinical trials that measure the impact of diabetes medications on outcomes that are important to patients.

"The medical community should insist that we invest the resources needed to do trials that ascertain the effect of interventions on patient-important outcomes. This policy will prevent the premature dissemination of therapies that ultimately prove harmful, facilitate patients' participation in decision making, and speed the day when we can confidently offer safe treatments that can provide important benefit to patients with diabetes," the authors said.

The authors have concluded that the focus should shift from getting new drugs to market to testing the effect of diabetes medications against outcomes important to patients

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Clinical Trials Diabetes - Essentials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Diabetes - Self-Monitoring of Blood Glucose (SMBG) Amoebic Dysentery 

Recommended Reading
Diabetes- First Aid and Emergency Treatment Guide
A quick and simple First Aid guide on how to administer treatment for Diabetes...
Diabetic Diet
DM as it is popularly called is a metabolic hormonal disorder. It is caused when the hormone ....
Amoebic Dysentery
Amoebic dysentery or amoebiasis is an infection of the intestine that causes diarrhoea most frequent...
Clinical Trials
Clinical trials are experiments that yield useful information to clinicians if a particular treatmen...
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Clinical Trials - The Past and The Future
Many of the drugs that are used today have been discovered by chance or often by mere serendipity...
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, sy...
Diabetes - Essentials
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels a...
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Di...
Diabetic Diet
The diabetic diet most often recommended is high in dietary fiber (especially soluble fiber) and nut...
Diabetic Retinopathy
The term Ďdiabetic retinopathyí refers to changes in the retina which often occur in people with ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use